Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Features
100%
Immune Parameters
100%
Molecular Features
100%
Oxidative Phosphorylation (OXPHOS)
100%
Metabolic Features
100%
Melanoma Brain Metastases
100%
Melanoma
13%
Oxidative Phosphorylation Inhibitors
13%
Immunohistochemistry
6%
Clinical Data
6%
Improved Survival
6%
Potential Therapeutics
6%
Therapeutic Strategies
6%
Gene Signature
6%
Immune Activation
6%
Rational Therapeutics
6%
RNA Sequencing (RNA-seq)
6%
Intracranial Tumor
6%
Metformin Treatment
6%
Craniotomy
6%
Metabolic
6%
Improved Outcomes
6%
Metabolic Pathway
6%
Clinical Phenotype
6%
B16F10
6%
Transcriptional Signature
6%
Alternative Therapeutics
6%
Glutamine Metabolism
6%
Gene Set
6%
Intracranial Metastases
6%
Intracranial Xenografts
6%
Functional Validation
6%
Molecular Phenotype
6%
Metabolic Phenotype
6%
Therapeutic Vulnerabilities
6%
RNA-seq Analysis
6%
Glutaminase Inhibitor
6%
CB-839
6%
Medicine and Dentistry
Melanoma
100%
Immunity
100%
Brain Metastasis
100%
Oxidative Phosphorylation
100%
RNA Sequencing
11%
Immunohistochemistry
5%
Metastatic Carcinoma
5%
Xenograft
5%
Intracranial Tumor
5%
Glycon
5%
Craniotomy
5%
Metabolism
5%
Glutamine
5%
Glutaminase
5%
RNA Sequence
5%
Biochemistry, Genetics and Molecular Biology
Immunity
100%
Oxidative Phosphorylation
100%
Metabolic Pathway
11%
RNA Sequencing
11%
Gene Signature
5%
RNA Sequence
5%
Glutamine
5%
Glutaminase
5%
Neuroscience
Oxidative Phosphorylation
100%
Metabolic Pathway
11%
RNA-Seq
11%
Immunohistochemistry
5%
Intracranial Tumor
5%
Glutamine
5%
RNA Sequence
5%
Metformin
5%
Craniotomy
5%
Glutaminase
5%